MedTrace Logo

Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers

NCT01088932 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2010-07-20

No results posted yet for this study

Summary

This is a multiple dose clinical study to be conducted with SRX246 capsules to determine the safety, tolerability and pharmacokinetics of the drug over a 14 day dosing period.

Conditions

  • Healthy

Interventions

DRUG

SRX246

capsules

Sponsors & Collaborators

  • Azevan Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Stephan A Bart, MD · SNBL Clinical Pharmacology Center

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088932 on ClinicalTrials.gov